Novel chemical genetic approaches to the discovery of signal transduction inhibitors

Drug Discovery Today

Volumn 7, Issue 16, 2002, Pages 872-879

  Shokat, Kevan ^a   Velleca, Mark ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cellular Genomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; IMATINIB; KINESIN; LIGAND; MYOSIN; PHOSPHATE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; TRASTUZUMAB; XANTHOSINE; ENZYME INHIBITOR; PHOSPHOTRANSFERASE;

ALLELE; BREAST CANCER; CHEMICAL GENETICS; CHRONIC MYELOID LEUKEMIA; DIMERIZATION; DRUG SCREENING; DRUG TARGETING; ENZYME ANALYSIS; ENZYME STRUCTURE; GASTROINTESTINAL TUMOR; GENOMICS; HUMAN; METHODOLOGY; NONHUMAN; PROTEIN ENGINEERING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TECHNOLOGY; VALIDATION PROCESS; X RAY CRYSTALLOGRAPHY; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MOLECULAR BIOLOGY;

ANIMAL; ENZYME INHIBITORS; HUMAN; MOLECULAR BIOLOGY; PHOSPHOTRANSFERASES; SIGNAL TRANSDUCTION; ANIMALS; HUMANS;

EID: 0037101904     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02391-7     Document Type: Review

References (32)

1. Chemogenomic approaches to drug discovery
2. Remodeling of yeast genome expression in response to environmental changes
3. The challenges of translating knockout phenotypes into gene function
4. Unnatural ligands for engineered proteins: New tools for chemical genetics
5. A mutation that alters the nucleotide specificity of elongation factor Tu, a GTP regulatory protein
6. Controlling signaling with a specifically designed Gi-coupled receptor
7. Conditional expression and signaling of a specifically designed G(i)-coupled receptor in transgenic mice
8. Neoceptor concept based on molecular complementarity in GPCRs: A mutant adenosine A3 receptor with selectively enhanced affinity for amine-modified nucleosides
9. Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR
10. Selective regulation of gene expression using rationally-modified retinoic acid receptors
11. The estrogen receptor: A structure-based approach to the design of new specific hormone-receptor combinations
12. Controlling signal transduction with synthetic ligands
13. TGF-β-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-β type I receptor fusion proteins
14. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization
15. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins
16. Rapid targeting of nuclear proteins to the cytoplasm
17. Dimeric ligands define a role for transcriptional activation domains in reinitiation
18. Rational design of orthogonal receptor-ligand combinations
19. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity
20. Designing small-molecule switches for protein-protein interactions
21. Magic bullets for protein kinases
22. A chemical switch for inhibitor-sensitive alleles of any protein kinase
23. Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme
24. Engineering Src family protein kinases with unnatural nucleotide specificity
25. Design of allele-specific inhibitors to probe protein kinase signaling
26. Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4p
27. Chemical inhibition of the Pho85 cyclin-dependent kinase reveals a role in the environmental stress response
28. Identification of new Jnk substrate using ATP pocket mutant Jnk and a corresponding ATP analogue
29. A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway
30. 6-modified ADP analogs
31. A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells
32. Allele-specific activators and inhibitors for kinesin